Navigation Links
Nu Skin Enterprises Declares Quarterly Dividend of $0.115
Date:6/4/2009

PROVO, Utah, June 4 /PRNewswire-FirstCall/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced the board of directors has declared a quarterly dividend of $0.115 per share, which will be paid on June 25, 2009, to stockholders of record on June 15, 2009.

The Company

For 25 years, Nu Skin Enterprises, Inc. has been demonstrating its tradition of innovation through its comprehensive anti-aging product portfolio, independent business opportunity and corporate social responsibility initiatives. Nu Skin's scientific leadership in both skin care and nutrition has established Nu Skin as a premier anti-aging company, evidenced in its patent-pending ageLOC(TM) technology and flagship products including the Galvanic Spa(R) System II, Tru Face(R) Essence Ultra, LifePak(R) nano and the g3 nutrition beverage. A global direct selling company, Nu Skin operates in 48 markets worldwide and has more than 750,000 independent sales representatives. Nu Skin Enterprises is traded on the New York Stock Exchange under the symbol "NUS." More information is available at http://www.nuskinenterprises.com.


'/>"/>
SOURCE Nu Skin Enterprises, Inc.
Copyright©2009 PR Newswire.
All rights reserved

3

GOOD

Page: 1

Related medicine news :

1. Nuvilex Signs Agreement with Jayhur Enterprises to Distribute Infinitink - the Worlds First Permanent, But Easier to Remove Tattoo Ink - in Australia and New Zealand
2. Nu Skin Enterprises to Announce First Quarter 2009 Results
3. Former National Century Financial Enterprises CEO Sentenced to 30 Years in Prison, Co-owner Sentenced to 25 Years in Prison for Conspiracy, Fraud and Money Laundering
4. iEnterprises Launches iComply, Lotus Notes Email Archiving and Compliance Software
5. Nu Skin Enterprises to Present at Bank of America and Merrill Lynch Consumer Conference
6. Arizona Technology Enterprises (AzTE) Hosts the ASU Tech Forum for the Investment Community
7. Nu Skin Enterprises Announces 5 Percent Increase in Quarterly Dividend
8. CTG HealthCare Solutions Ranked Second in Overall Professional Services Firm Category by KLAS Enterprises
9. Nu Skin Enterprises to Announce Fourth Quarter and Year-End 2008 Results
10. Nu Skin Enterprises Receives Broader Direct Selling Authorization in China
11. FFF Enterprises Launches New MyFluVaccine Website
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 2TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 3Reportlinker Adds Medical Fiber Optics - A World Market Analysis 2Reportlinker Adds Medical Fiber Optics - A World Market Analysis 3Reportlinker Adds Medical Fiber Optics - A World Market Analysis 4Reportlinker Adds Medical Fiber Optics - A World Market Analysis 5Reportlinker Adds Medical Fiber Optics - A World Market Analysis 6Connectyx Technologies Holdings Group Inc Signs an Agreement with Healthy Directions LLC Americas Largest Publisher of Alternative and Complementa 50627 1Connectyx Technologies Holdings Group Inc Signs an Agreement with Healthy Directions LLC Americas Largest Publisher of Alternative and Complementa 50627 2Is Financial Infidelity a Threat to Your Marriage 3F Psychiatrist Says It Can Be More Devastating Than an Affair 50624 1Is Financial Infidelity a Threat to Your Marriage 3F Psychiatrist Says It Can Be More Devastating Than an Affair 50624 2Omega Medical Solutions Selects Allscripts Practice Management and Allscripts Payerpath Revenue Cycle Management 50621 1Omega Medical Solutions Selects Allscripts Practice Management and Allscripts Payerpath Revenue Cycle Management 50621 2Omega Medical Solutions Selects Allscripts Practice Management and Allscripts Payerpath Revenue Cycle Management 50621 3Omega Medical Solutions Selects Allscripts Practice Management and Allscripts Payerpath Revenue Cycle Management 50621 4Omega Medical Solutions Selects Allscripts Practice Management and Allscripts Payerpath Revenue Cycle Management 50621 5